146 related articles for article (PubMed ID: 12244153)
1. Effector CD4 cells are tolerized upon exposure to parenchymal self-antigen.
Higgins AD; Mihalyo MA; Adler AJ
J Immunol; 2002 Oct; 169(7):3622-9. PubMed ID: 12244153
[TBL] [Abstract][Full Text] [Related]
2. CD4 cell priming and tolerization are differentially programmed by APCs upon initial engagement.
Higgins AD; Mihalyo MA; McGary PW; Adler AJ
J Immunol; 2002 Jun; 168(11):5573-81. PubMed ID: 12023353
[TBL] [Abstract][Full Text] [Related]
3. Steady state dendritic cells present parenchymal self-antigen and contribute to, but are not essential for, tolerization of naive and Th1 effector CD4 cells.
Hagymasi AT; Slaiby AM; Mihalyo MA; Qui HZ; Zammit DJ; Lefrancois L; Adler AJ
J Immunol; 2007 Aug; 179(3):1524-31. PubMed ID: 17641018
[TBL] [Abstract][Full Text] [Related]
4. In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapy.
Mihalyo MA; Doody AD; McAleer JP; Nowak EC; Long M; Yang Y; Adler AJ
J Immunol; 2004 May; 172(9):5338-45. PubMed ID: 15100273
[TBL] [Abstract][Full Text] [Related]
5. Impact of effector cell differentiation on CD4+ T cells that evade negative selection by a self-peptide.
Boesteanu A; Rankin AL; Caton AJ
Int Immunol; 2006 Jul; 18(7):1017-27. PubMed ID: 16702167
[TBL] [Abstract][Full Text] [Related]
6. Novel phenotypes and migratory properties distinguish memory CD4 T cell subsets in lymphoid and lung tissue.
Bingaman AW; Patke DS; Mane VR; Ahmadzadeh M; Ndejembi M; Bartlett ST; Farber DL
Eur J Immunol; 2005 Nov; 35(11):3173-86. PubMed ID: 16220537
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: virus-specific CD4+ memory T cells in nonlymphoid tissues express a highly activated phenotype.
Cauley LS; Cookenham T; Miller TB; Adams PS; Vignali KM; Vignali DA; Woodland DL
J Immunol; 2002 Dec; 169(12):6655-8. PubMed ID: 12471092
[TBL] [Abstract][Full Text] [Related]
8. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection.
Oxenius A; Bachmann MF; Zinkernagel RM; Hengartner H
Eur J Immunol; 1998 Jan; 28(1):390-400. PubMed ID: 9485218
[TBL] [Abstract][Full Text] [Related]
9. CD4+ T cells pass through an effector phase during the process of in vivo tolerance induction.
Huang CT; Huso DL; Lu Z; Wang T; Zhou G; Kennedy EP; Drake CG; Morgan DJ; Sherman LA; Higgins AD; Pardoll DM; Adler AJ
J Immunol; 2003 Apr; 170(8):3945-53. PubMed ID: 12682221
[TBL] [Abstract][Full Text] [Related]
10. CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells.
Adler AJ; Marsh DW; Yochum GS; Guzzo JL; Nigam A; Nelson WG; Pardoll DM
J Exp Med; 1998 May; 187(10):1555-64. PubMed ID: 9584134
[TBL] [Abstract][Full Text] [Related]
11. Mapping of the lingual immune system reveals the presence of both regulatory and effector CD4+ T cells.
Mascarell L; Lombardi V; Zimmer A; Louise A; Tourdot S; Van Overtvelt L; Moingeon P
Clin Exp Allergy; 2009 Dec; 39(12):1910-9. PubMed ID: 19694757
[TBL] [Abstract][Full Text] [Related]
12. Autoreactive T cells revealed in the normal repertoire: escape from negative selection and peripheral tolerance.
Yan J; Mamula MJ
J Immunol; 2002 Apr; 168(7):3188-94. PubMed ID: 11907071
[TBL] [Abstract][Full Text] [Related]
13. T-cell activation occurs simultaneously in local and peripheral lymphoid tissue following oral administration of a range of doses of immunogenic or tolerogenic antigen although tolerized T cells display a defect in cell division.
Smith KM; Davidson JM; Garside P
Immunology; 2002 Jun; 106(2):144-58. PubMed ID: 12047744
[TBL] [Abstract][Full Text] [Related]
14. Histone acetylation at the Ifng promoter in tolerized CD4 cells is associated with increased IFN-gamma expression during subsequent immunization to the same antigen.
Long M; Slaiby AM; Wu S; Hagymasi AT; Mihalyo MA; Bandyopadhyay S; Vella AT; Adler AJ
J Immunol; 2007 Nov; 179(9):5669-77. PubMed ID: 17947638
[TBL] [Abstract][Full Text] [Related]
15. Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells.
Lo D; Freedman J; Hesse S; Palmiter RD; Brinster RL; Sherman LA
Eur J Immunol; 1992 Apr; 22(4):1013-22. PubMed ID: 1348026
[TBL] [Abstract][Full Text] [Related]
16. Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen.
Thorstenson KM; Khoruts A
J Immunol; 2001 Jul; 167(1):188-95. PubMed ID: 11418648
[TBL] [Abstract][Full Text] [Related]
17. In vivo CD4+ T cell tolerance induction versus priming is independent of the rate and number of cell divisions.
Adler AJ; Huang CT; Yochum GS; Marsh DW; Pardoll DM
J Immunol; 2000 Jan; 164(2):649-55. PubMed ID: 10623806
[TBL] [Abstract][Full Text] [Related]
18. A lung-specific neo-antigen elicits specific CD8+ T cell tolerance with preserved CD4+ T cell reactivity. Implications for immune-mediated lung disease.
Enelow RI; Stoler MH; Srikiatkhachorn A; Kerlakian C; Agersborg S; Whitsett JA; Braciale TJ
J Clin Invest; 1996 Aug; 98(4):914-22. PubMed ID: 8770862
[TBL] [Abstract][Full Text] [Related]
19. Novel mechanisms underlying the immediate and transient global tolerization of splenic dendritic cells after vaccination with a self-antigen.
Farkas AM; Finn OJ
J Immunol; 2014 Jan; 192(2):658-65. PubMed ID: 24337381
[TBL] [Abstract][Full Text] [Related]
20. Self-antigen prevents CD8 T cell effector differentiation by CD134 and CD137 dual costimulation.
Bandyopadhyay S; Long M; Qui HZ; Hagymasi AT; Slaiby AM; Mihalyo MA; Aguila HL; Mittler RS; Vella AT; Adler AJ
J Immunol; 2008 Dec; 181(11):7728-37. PubMed ID: 19017962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
